Ovarian response markers lead to appropriate and effective use of corifollitropin alpha in assisted reproduction

Reproductive BioMedicine Online

Volumn 28, Issue 2, 2014, Pages 183-190

  La Marca, Antonio ^a   D'Ippolito, Giovanni ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

anti M llerian hormone; antral follicle count; corifollitropin alpha; IVF; OHSS; ovarian stimulation

Indexed keywords

ANTI-MÜLLERIAN HORMONE; ANTRAL FOLLICLE COUNT; CORIFOLLITROPIN ALPHA; IVF; OHSS; OVARIAN STIMULATION;

ANTI-MULLERIAN HORMONE; BIOLOGICAL MARKERS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLICLE STIMULATING HORMONE, HUMAN; HUMANS; OVARIAN FOLLICLE; OVARIAN HYPERSTIMULATION SYNDROME; OVARY; OVULATION INDUCTION; PREGNANCY;

EID: 84895075036     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/j.rbmo.2013.10.012     Document Type: Review

References (47)

1. A. Aflatoonian, H. Oskouian, S. Ahmadi, and L. Oskouian Prediction of high ovarian response to controlled ovarian hyperstimulation: anti-Müllerian hormone versus small antral follicle count (2-6 mm) J. Assist. Reprod. Genet. 26 2009 319 325
2. A.H. Balen, A.G. Mulders, B.C. Fauser, B.C. Schoot, M.A. Renier, P. Devroey, M.J. Struijs, and B.M. Mannaerts Pharmacodynamics of a single low dose of long-acting recombinant follicle-stimulating hormone (FSH-carboxy terminal peptide, corifollitropin alfa) in women with World Health Organization group II anovulatory infertility J. Clin. Endocrinol. Metab. 89 2004 6297 6304
3. R. Boostanfar, B. Mannaerts, S. Pang, M. Fernandez-Sanchez, H. Witjes, and P. Devroey Engage investigators. A comparison of live birth rates and cumulative ongoing pregnancy rates between Europe and North America after ovarian stimulation with corifollitropin alfa or recombinant follicle-stimulating hormone Fertil. Steril. 97 2012 1351 1358
4. R. Boostanfar, T. Yeko, B. Shapiro, J. Elbers, H. Witjes, and B. Mannaerts A large double blind efficacy and safety trial of corifollitropin alfa versus daily recombinant FSH in women 35 to n42 years of age undergoing ovarian stimulation prior to IVF or ICSI (Pursue trial) Fertil. Steril. 98 2012 S34
5. G. Borm, and B. Mannaerts Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran study group Hum. Reprod. 15 2001 1490 1498
6. P.M. Bouloux, D.J. Handelsman, F. Jockenhövel, E. Nieschlag, J. Rabinovici, W.L. Frasa, J.J. de Bie, G. Voortman, and J. Itskovitz-Eldor FSH-CTP study group. First human exposure to FSH-CTP in hypogonadotrophic hypogonadal males Hum. Reprod. 16 2001 1592 1597
7. S.L. Broer, M. Dólleman, B.C. Opmeer, B.C. Fauser, B.W. Mol, and F.J. Broekmans AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis Hum. Reprod. Update 17 2011 46 54
8. Corifollitropin Alfa Dose-finding Study Group A randomized dose-response trial of a single injection of corifollitropin alfa to sustain multifollicular growth during controlled ovarian stimulation Hum. Reprod. 23 2008 2484 2492
9. Corifollitropin alfa Ensure Study Group Corifollitropin alfa for ovarian stimulation in IVF: a randomized trial in lower-body-weight women Reprod Biomed Online 21 2010 66 76
10. R. de Greef, A.S. Zandvliet, A.F. de Haan, P.C. Ijzerman-Boon, M. Marintcheva-Petrova, and B.M. Mannaerts Dose selection of corifollitropin alfa by modeling and simulation in controlled ovarian stimulation Clin. Pharmacol. Ther. 88 2010 424
11. R. de Leeuw, J. Mulders, G. Voortman, F. Rombout, J. Damm, and L. Kloosterboer Structure-function relationship of recombinant follicle stimulating hormone (Puregon) Mol. Hum. Reprod. 2 1996 361 369
12. P. Devroey, B.C. Fauser, P. Platteau, N.G. Beckers, M. Dhont, and B.M. Mannaerts Induction of multiple follicular development by a single dose of long-acting recombinant follicle-Stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization J. Clin. Endocrinol. Metab. 89 2004 2062 2070
13. P. Devroey, R. Boostanfar, N.P. Koper, B.M. Mannaerts, P.C. Ijzerman-Boon, and B.C. Fauser ENGAGE Investigators. A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol Hum. Reprod. 24 2009 3063 3072
14. I.J. Duijkers, C. Klipping, P.J. Boerrigter, C.S. Machielsen, J.J. De Bie, and G. Voortman Single dose pharmacokinetics and effects on follicular growth and serum hormones of a long-acting recombinant FSH preparation (FSH-CTP) in healthy pituitary-suppressed females Hum. Reprod. 17 2002 1987 1993
15. T. Eldar-Geva, A. Ben-Chetrit, I.M. Spitz, R. Rabinowitz, E. Markowitz, T. Mimoni, M. Gal, E. Zylber-Haran, and E.J. Margalioth Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome Hum. Reprod. 20 2005 3178 3183
16. European and Middle East Orgalutran Study Group Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation Hum. Reprod. 16 2001 644 651
17. F.A. Fares, N. Suganuma, K. Nishimori, P.S. LaPolt, A.J. Hsueh, and I. Boime Design of a long-acting follitropin agonist by fusing the C-terminal sequence of the chorionic gonadotropin beta subunit to the follitropin beta subunit Proc. Natl. Acad. Sci. U. S. A 89 1992 4304 4308
18. B.C. Fauser, B.M. Mannaerts, P. Devroey, A. Leader, I. Boime, and D.T. Baird Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency Hum. Reprod. Update 15 2009 309 321
19. B.C. Fauser, M.M. Alper, W. Ledger, W.B. Schoolcraft, and A. Zandvliet Mannaerts BM; Engage Investigators. Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF Reprod Biomed Online. 21 2010 593 601
20. C.M. Howles Genetic engineering of human FSH (Gonal-F) Hum. Reprod. Update. 2 1996 172 191
21. P. Humaidan, E.G. Papanikolaou, and B.C. Tarlatzis GnRHa to trigger final oocyte maturation: a time to reconsider Hum. Reprod. 24 2009 2389 2394
22. J. Kwee, R. Schats, J. McDonnell, A. Themmen, F. de Jong, and C. Lambalk Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserve Fertil. Steril. 90 2008 737 743
23. A. La Marca, S. Giulini, A. Tirelli, E. Bertucci, T. Marsella, S. Xella, and A. Volpe Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology Hum. Reprod. 22 2007 766 771
24. A. La Marca, G. Sighinolfi, D. Radi, C. Argento, E. Baraldi, A.C. Artenisio, G. Stabile, and A. Volpe Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART) Hum. Reprod. Update. 16 2010 113 130
25. A. La Marca, E. Spada, G. Sighinolfi, C. Argento, A. Tirelli, S. Giulini, S. Milani, and A. Volpe Age-specific nomogram for the decline in antral follicle count throughout the reproductive period Fertil. Steril. 95 2011 684 688
26. A. La Marca, and S.K. Sunkara Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice Hum. Reprod. Update. 20 2014 124 140
27. P.S. LaPolt, K. Nishimori, F.A. Fares, E. Perlas, I. Boime, and A.J. Hsueh Enhanced stimulation of follicle maturation and ovulatory potential by long acting follicle-stimulating hormone agonists with extended carboxyl-terminal peptides Endocrinology 131 1992 2514 2520
28. J.Y. le Cotonnec, E. Loumaye, H.C. Porchet, V. Beltrami, and A. Munafo Pharmacokinetic and pharmacodynamic interactions between recombinant human luteinizing hormone and recombinant human follicle-stimulating hormone Fertil. Steril. 69 1998 201 209
29. W.L. Ledger, B.C. Fauser, P. Devroey, A.S. Zandvliet, and B.M. Mannaerts Corifollitropin alfa doses based on body weight: clinical overview of drug exposure and ovarian response Reprod. Biomed. Online 23 2010 150 159
30. T.H. Lee, C.H. Liu, C.C. Huang, Y.L. Wu, Y.T. Shih, H.N. Ho, Y.S. Yang, and M.S. Lee Serum anti-Müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles Hum. Reprod. 23 2008 160 167
31. E. Loumaye, I. Martineau, A. Piazzi, L. O'Dea, S. Ince, C. Howles, G. Decosterd, K. Van Loon, and A. Galazka Clinical assessment of human gonadotrophins produced by recombinant DNA technology Hum. Reprod. 11 1996 95 107
32. D. Loutradis, A. Vlismas, and P. Drakakis Corifollitropin alfa: a novel long-acting recombinant follicle-stimulating hormone agonist for controlled ovarian stimulation Womens Health (Lond. Engl.) 6 2010 655 664
33. L.G. Nardo, T.A. Gelbaya, H. Wilkinson, S.A. Roberts, A. Yates, P. Pemberton, and I. Laing Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization Fertil. Steril. 92 2009 1586 1593
34. S.M. Nelson, R.W. Yates, and R. Fleming Serum anti-Müllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles-implications for individualization of therapy Hum. Reprod. 22 2007 2414 2421
35. E.H. Ng, W.S. Yeung, and P.C. Ho The significance of antral follicle count in controlled ovarian stimulation and intrauterine insemination J. Assist. Reprod. Genet. 22 2005 323 328
36. P. Ocal, S. Sahmay, M. Cetin, T. Irez, O. Guralp, and I. Cepni Serum anti-Müllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles J. Assist. Reprod. Genet. 28 2011 1197 1203
37. W. Olijve, W. de Boer, J.W. Mulders, and P.M. van Wezenbeek Molecular biology and biochemistry of human recombinant follicle stimulating hormone (Puregon) Mol. Hum. Reprod. 2 1996 371 382
38. N.P. Polyzos, M. Devos, P. Humaidan, D. Stoop, C. Ortega-Hrepich, P. Devroey, and H. Tournaye Corifollitropin alfa followed by rFSH in a GnRH antagonist protocol for poor ovarian responder patients: an observational pilot study Fertil. Steril. 99 2013 422 426
39. Polyzos NP, Tournaye H, Guzman L, Camus M, Nelson SM. Predictors of ovarian response in women treated with corifollitropin alfa for in vitro fertilization/intracytoplasmic sperm injection. Fertil Steril. 2013b May 11 [Epub ahead of print].
40. H.C. Porchet, J.Y. le Cotonnec, and E. Loumaye Clinical pharmacology of recombinant human follicle-stimulating hormone. III. Pharmacokinetic- pharmacodynamic modelling after repeated subcutaneous administration Fertil. Steril. 61 1994 687 695
41. J. Pundir, S.K. Sunkara, T. El-Toukhy, and Y. Khalaf Meta-analysis of GnRH antagonist protocols: do they reduce the risk of OHSS in PCOS? Reprod. Biomed. Online 24 2012 6 22
42. R. Quinton, P.M. Bouloux, J.M. Illingworth, I. Martineau, and E. Loumaye Efficacy of recombinant follicle-stimulating hormone Fertil. Steril. 66 1996 164 169
43. A. Requena, M. Cruz, D. Ollado, A. Izquierdo, A. Ballesteros, M. Munoz, and J.A. Garcia-Velasco Evaluation of the degree of satisfaction in oocytes donors using sustained-release FSH corifollitropin alfa Reprod. Biomed. Online 26 2013 53 59
44. B.C. Tarlatzis, G. Griesinger, A. Leader, L. Rombauts, P.C. Ijzerman-Boon, and B.M. Mannaerts Comparative incidence of ovarian hyperstimulation syndrome following ovarian stimulation with corifollitropin alfa or recombinant FSH Reprod. Biomed. Online 24 2012 410 419
45. I.A. van Rooij, F.J. Broekmans, E.R. te Velde, B.C. Fauser, L.F. Bancsi, F.H. de Jong, and A.P. Themmen Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve Hum. Reprod. 17 2002 3065 3071
46. M.F. Verberg, M.J. Eijkemans, E.M. Heijnen, F.J. Broekmans, C. de Klerk, B.C. Fauser, and N.S. Macklon Why do couples drop-out from IVF treatment? A prospective cohort study Hum. Reprod. 23 2008 2050 2055
47. E. Zivi, A. Simon, and N. Laufer Ovarian hyperstimulation syndrome: definition, incidence, and classification Semin. Reprod. Med. 28 2010 441 447